This user doesn't have any favorites yet.
1. Kuo G. The prevalent use of natural products and the effects on warfarin Interactions - Oregon Society of Health-System Pharmacists. 1998;22(4): 9-11.
2. Kuo G. New drugs for 1999. In: Rakel RE, Bope ET, eds. Conn’s Current Therapy. 53rd ed. Philadelphia, PA: W. B. Saunders; 2001:1263.
3. Kuo GM. Fenugreek: A Systematic Review. In: Basch, EM, Ulbricht CE, Bent S, Boon H, Smith M, eds. Natural Standard Evidence-Based Clinical Guide. Boston, MA: Natural Standard Publishing, 2002 (www.naturalstandard.com).
4. Kuo GM. New drugs for 2000. In: Rakel RE, Bope ET, eds. Conn’s Current Therapy. 54rd ed. Philadelphia, PA: W. B. Saunders; 2002: 1246-7.
5. Kuo GM, DeVore V, Simpson L. Communication and Counseling of Dietary Needs and the Role of the Pharmacist. In: Williams L, Wolinski I, eds. Nutrition Reference for Pharmacists. American Pharmaceutical Association; 2002.
6. Kuo GM. Pharmacodynamic basis of herbal medicine. Ann Pharmacother 2003;37(2):308. [Book Review].
7. McGriff-Lee NJ, Csako G, Chen JT, Dang DK, Rosenfeld KG, Cannon RO, Macklin LR, Wesley RA; Anticoagulation Working Group [Kuo GM]. Search for predictors of nontherapeutic INR results with warfarin therapy. Ann Pharmacother. 2005;39(12):1996-2002.
8. Kuo GM and Pinon M. Advanced (specialty) experiential education. In: Cuellar LM and Ginsburg, editors. Preceptor’s handbook for pharmacists. Bethesda (MD): American Society of Health-System Pharmacist; 2005. p. 134-41.
9. Kuo GM. Establishing an effective preceptor/student relationship. In: Cuellar LM and Ginsburg, editors. Preceptor’s handbook for pharmacists. Bethesda (MD): American Society of Health-System Pharmacist; 2005. p.108-10.
10. Kuo GM. Creating an environment that promotes a win-win situation for preceptors and students. In: Cuellar LM and Ginsburg, editors. Preceptor’s handbook for pharmacists. Bethesda (MD): American Society of Health-System Pharmacist; 2005. p. 123-7.11.
11. Kuo GM. Non-steroidal anti-inflammatory drugs. In: Boswell MV and Cole BE, editors. Weiner’s Pain Management: A Practical Guide for Clinicians. 7th ed. (American Academy of Pain Management) Boca Raton (FL): CRC Press, 2005. p.773-88.
12. Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, Volk RJ. Management of of type 2 diabetes in the primary care setting: a practice-based research network study [Kuo GM, contributed in data collection, management, and analysis]. Ann Fam Med. 2006; 4(1):23-31. Available at: http://www.annfammed.org/cgi/content/full/4/1/23.
13. IOM Committee on identifying and preventing medication errors [Kuo GM, contributing author]. Preventing medication errors: quality chasm series. Aspden, P., Wolcott, J., Bootman, J.L., Cronenwett, L.R. (eds). Washington DC: The National Academies Press; 2006.
14. Kuo GM. Medication errors in community/ambulatory care: incidence and reduction strategies. Journal of Pharmaceutical Finance, Economics and Policy 2006;15(3):43-136.
15. Binns HJ, Lanier D, Pace WD, Galliher JM, Ganiats TG, Grey M, Ariza AJ, Williams R; for the Primary Care Network Survey (PRINS) Participants [Kuo G, SPUR-Net participant]. Describing primary care encounters: The Primary Care Network Survey and The National Ambulatory Medical Care Survey. Ann Fam Med 2007;5:39-47.
16. Figg WD, Chau CH, Okita R, et al [Kuo GM, invited conference attendee]. Pharm.D. Pathways to Biomedical Research: The National Institutes of Health Special Conference on Pharmacy Research. Pharmacotherapy 2008;28(7):821-33.
http://myprofile.cos.com/gkuo